Sialidases Affect the Host Cell Adherence and Epsilon Toxin-Induced Cytotoxicity of Clostridium perfringens Type D Strain CN3718 by Li, Jihong et al.
Sialidases Affect the Host Cell Adherence and Epsilon
Toxin-Induced Cytotoxicity of Clostridium perfringens
Type D Strain CN3718
Jihong Li
1, Sameera Sayeed
2, Susan Robertson
1, Jianming Chen
1, Bruce A. McClane
1*
1Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America, 2Department of
Environmental and Occupational Health, University of Pittsburgh, Pennsylvania, United States of America
Abstract
Clostridium perfringens type B or D isolates, which cause enterotoxemias or enteritis in livestock, produce epsilon toxin (ETX).
ETX is exceptionally potent, earning it a listing as a CDC class B select toxin. Most C. perfringens strains also express up to
three different sialidases, although the possible contributions of those enzymes to type B or D pathogenesis remain unclear.
Type D isolate CN3718 was found to carry two genes (nanI and nanJ) encoding secreted sialidases and one gene (nanH)
encoding a cytoplasmic sialidase. Construction in CN3718 of single nanI, nanJ and nanH null mutants, as well as a nanI/nanJ
double null mutant and a triple sialidase null mutant, identified NanI as the major secreted sialidase of this strain.
Pretreating MDCK cells with NanI sialidase, or with culture supernatants of BMC206 (an isogenic CN3718 etx null mutant that
still produces sialidases) enhanced the subsequent binding and cytotoxic effects of purified ETX. Complementation of
BMC207 (an etx/nanH/nanI/nanJ null mutant) showed this effect is mainly attributable to NanI production. Contact between
BMC206 and certain mammalian cells (e.g., enterocyte-like Caco-2 cells) resulted in more rapid sialidase production and this
effect involved increased transcription of BMC206 nanI gene. BMC206 was shown to adhere to some (e.g. Caco-2 cells), but
not all mammalian cells, and this effect was dependent upon sialidase, particularly NanI, expression. Finally, the sialidase
activity of NanI (but not NanJ or NanH) could be enhanced by trypsin. Collectively these in vitro findings suggest that,
during type D disease originating in the intestines, trypsin may activate NanI, which (in turn) could contribute to intestinal
colonization by C. perfringens type D isolates and also increase ETX action.
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Introduction
Clostridium perfringens, a Gram-positive, spore-forming anaerobe,
is an important pathogen of both humans (causing, for example,
gas gangrene and type A human food poisoning) and livestock
(causing severe enterotoxemias and enteritis) [1]. The virulence of
this bacterium is largely attributable to its ability to express a
plethora of potent toxins. However, while C. perfringens can
produce .15 different toxins, individual strains express only
portions of this toxin arsenal [1-3]. Therefore, based upon
production of four typing toxins (a, b, e, and i), isolates of this
organism are commonly classified into five toxinotypes (type A
through E) [4].
By definition, C. perfringens type D isolates must produce alpha
and epsilon toxins, while type B isolates must express alpha, beta
and epsilon toxin [4]. Beyond those typing toxins, type D and type
B isolates commonly produce additional toxins, e.g., perfringolysin
O, enterotoxin, TpeL or beta2 toxin [5-7]. Type B and D isolates
cause enterotoxemias in livestock that initiate with toxin
production in the intestines, followed by absorption of those
toxins into the circulation to affect other internal organs, such as
the brain and kidneys. Type D isolates can also cause acute or
chronic enteritis in goats [1,8,9].
Epsilon toxin (ETX) is considered important for the virulence of
both type B and type D isolates [5,6]. This CDC class B select
toxin, which ranks as the third most-potent clostridial toxin after
the botulinum toxins and tetanus toxin, belongs to the aerolysin
family of pore-forming toxins [9,10]. ETX is synthesized and
secreted as an inactive prototoxin of 311 amino acids (32.7 kDa).
In the animal intestines, the prototoxin can be proteolytically
activated to the fully-active toxin (274 amino acids) by trypsin and
chymotrypsin [11].
To date, only a few ETX-sensitive cultured cell lines have been
identified, including MDCK cells, mpkCCDc14 cells, and human
leiomyoblastoma (G402) cells [11]. The mechanism of ETX action
on MDCK cells is still under active study but first involves the
binding of this toxin to unidentified protein receptors on the
MDCK cell membrane surface. The bound toxin then uses lipid
rafts to form a heptameric prepore complex on the membrane
surface [12,13]. When this prepore complex inserts into the cell
membrane, an active pore is created that causes, or strongly
contributes to, MDCK cell death [9].
Genome sequencing has revealed that C. perfringens strains
typically possess three sialidase-encoding genes, named nanH, nanI
and nanJ, which are located on a conserved region of the
chromosome [14-16]. The nanH gene product, which is not
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the secreted ,77 kDa NanI sialidase, while the nanJ gene product
is the secreted ,129 kDa NanJ sialidase. The nanH ORF shares
only 19% nucleotide sequence identity with nanI and nanJ, but the
ORFs encoding the two larger exoenzymes are more closely
related, sharing 57% nucleotide sequence identity [17].
Sialidase (neuraminidases) production by some pathogenic
bacteria has been implicated in their virulence. For example,
Vibrio cholerae sialidase enhances the activity of cholera toxin by
modifying surface gangliosides to create additional toxin receptors
and thereby increase toxin binding levels [18]. Sialidases can also
apparently contribute to virulence in other ways besides enhancing
toxin binding. For example, neuramindases are thought to assist
Streptococcus pneumoniae pathogenesis by providing nutrients for
growth, assisting in biofilm formation, and enhancing colonization
by exposing adhesion sites for this bacterium in the airways [19].
Possible sialidase contributions to C. perfringens virulence have
received only limited attention. A recent study [20] used mutants
to evaluate the potential pathogencity contributions of NanI and
NanJ sialidase when C. perfringens type A strain 13 causes clostridial
myonecrosis (gas gangrene). That study [20] found sialidases can
enhance alpha-toxin-mediated cytotoxic effects in vitro, but also
reported that sialidase production is not necessary for strain 13 to
cause gas gangrene in a mouse model. Possible virulence
contributions of sialidases when other C. perfringens strains, such
as type D strains, cause disease originating in the intestines has
received even less study. It was reported that sialidases can
enhance ETX cytotoxicity towards MDCK cells [21], but an
apparently contradictory conclusion was reached by another study
determining that treatment of synaptosomal membrane fractions
with sialidases lowered ETX binding levels [22].
The current study has used both biochemical and isogenic
mutant approaches to better evaluate the possible sialidase
enhancement of in vitro ETX action. In addition, a possible role
for sialidases in facilitating C. perfringens cell adhesion to host cells
was examined for the first time. Results of these in vitro studies
suggest that sialidases could contribute to type D pathogenesis via
at least two distinct mechanisms.
Results
Pretreatment of MDCK cells with purified C. perfringens
NanI sialidase enhances ETX cytotoxicity, binding and
complex formation
To clarify whether C. perfringens sialidases can enhance ETX
cytotoxicity in sensitive mammalian cells, MDCK cells were
pretreated with purified C. perfringens NanI sialidase and, after
washing, those cells were challenged with purified ETX. The
results showed that sialidase pretreatment substantially increased
ETX-induced cytotoxicity (Figure 1A). This enhancement was
stronger using a 0.005 U/ml vs. a 0.001 U/ml dose of sialidase for
the pretreatment. However, while enhancement of ETX cytotox-
icity increased up to a 90 min sialidase pretreatment using the
0.001 U/ml NanI dose, the higher 0.005 U/ml NanI dose caused
no further increase in cytotoxicity beyond a 60 min pretreatment
(Figure 1A). Sialidase treatment alone, or treatment with
prototoxin, did not increase cytotoxicity above background levels
(data not shown).
Experiments were then performed to explore the mechanistic
basis behind the sialidase-induced enhancement of ETX cytotox-
icity for MDCK cells that was shown in Figure 1A. First, MDCK
cells were pretreated with purified C. perfringens NanI sialidase and,
after washing, those cells were incubated with Alexa Fluor 488-
labeled epsilon prototoxin (AF488-pETX), which was used since it
binds similarly as active ETX to MDCK cells, yet causes no
cytotoxicity [23]. Results from this experiment (Figure 1B) showed
that pretreating MDCK cells with either 0.001 U/ml or 0.005 U/
ml of purified NanI sialidase substantially increased subsequent
AF488-pETX binding levels. This enhancement of toxin binding
increased with longer sialidase pretreatment time, although no
further increase in AF488-pETX binding was noted after a 60 min
sialidase pretreatment beyond the 0.005 U/ml sialidase dose
(Figure 1B).
An experiment then assessed the ability of sialidase pretreatment
to increase formation of the ETX oligomeric complex that is
considered responsible for pore formation-induced ETX cytotox-
icity [9]. SDS-PAGE analyses of MDCK cell lysates treated with
5 mg/ml of Alexa Fluor 488-labeled ETX (AF488-ETX) detected
an increased formation of the ETX oligomeric complex after NanI
pretreatment (Figure 1C and 1D). This effect increased up to a
60 min pretreatment with 0.005 U/ml of NanI. Lastly, similar
NanI pretreatment also increased MDCK cell binding and
complex formation using a 10 mg/ml dose of AF488-pETX or
AF488-ETX, respectively (data not shown).
Construction and genotypic characterization of isogenic
CN3718 sialidase mutants
The Figure 1 results indicated that pretreating MDCK cells
with purified C. perfringens NanI sialidase can enhance ETX
cytotoxicity by increasing toxin binding and thus, complex
formation. Therefore, we next sought to assess whether sialidases
also contribute to ETX-induced cytotoxicity when these glycoside
hydrolyases are expressed at natural levels and in the natural
presence of other C. perfringens exoproducts, including other toxins.
To initiate this work, we first surveyed sialidase activity in 6 h and
overnight supernatants from cultures of various C. perfringens
isolates (Figure 2). This survey detected considerable strain-to-
strain variations in supernatant sialidase activity and also identified
type D strain CN3718 as a moderately high sialidase producer.
Since CN3718 is also transformable and produces ETX (see
below), it was chosen for construction of sialidase mutants.
PCR analyses first determined that CN3718 carries all three
identified C. perfringens sialidase genes (data not shown), including
Author Summary
Clostridium perfringens type D strains cause enteritis and
enterotoxemias in livestock after colonizing the intestines
and then producing toxins, notably epsilon toxin (ETX).
Initially produced and secreted in an inactive form, ETX can
be rapidly proteolytically-activated by trypsin and other
intestinal proteases. While most C. perfringens strains
produce three sialidases, no pathogenic role has yet been
identified for these enzymes that remove terminal sialic
acid residues from glycoproteins and glycolipids. Our
current study found that trypsin increases the activity of
the NanI sialidase made by type D strain CN3718. This
effect enhanced the ability of NanI to modify the surface of
MDCK cells, leading to increased ETX binding and
cytotoxicity. We also found that modification of the host
cell surface by NanI sialidase allows efficient attachment of
CN3718 cells to Caco-2 cells. These results identify
interactions between intestinal proteases, ETX, sialidases,
and ETX-producing bacteria, whereby trypsin activates not
only ETX but also NanI sialidase. If similar effects occur in
the intestines, the activated NanI sialidase may modify the
host cell surface to facilitate bacterial attachment and
thereby worsen disease by facilitating intestinal coloniza-
tion by type D strains to prolong toxin delivery and, in
some species, increase ETX binding.
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sialidases, and nanH, which encodes the NanH sialidase that lacks
a signal peptide and thus localizes in the cytoplasm. Therefore, the
current study used a Clostridium-modified Targetron insertional
mutagenesis method [24] to construct isogenic single nanH, nanI,
and nanJ null mutants, a nanI/nanJ double null mutant, and a
nanH/nanI/nanJ triple null mutant in a CN3718 background.
The identity of the CN3718 nanJ, nanI and nanH single null
mutants (named BMC201, BMC202 and BMC203, respectively)
was first demonstrated by PCR using primers specific for internal
nanJ ORF, nanI ORF or nanH ORF sequences. Using DNA from
wild-type CN3718, these internal PCR primers specifically
amplified the expected PCR products of 306 bp for nanJ,
467 bp for nanI, and 285 bp for nanH (data not shown). However,
consistent with the insertion of an ,900 bp intron into the target
ORF, the same primers amplified PCR products of ,1200 bp,
,1400 bp, and ,1200 bp for the nanJ, nanI and nanH null
mutants, respectively (data not shown). Those PCR assays also
confirmed the identity of a nanJ/I double null mutant (BMC204)
and a nanJ/I/H triple null mutant (BMC205) constructed by
Targetron technology (data not shown). The nanJ/I double null
mutant PCR supported amplification of two larger bands, which
matched the product sizes of a disrupted nanJ gene and nanI gene,
along with a small band matching the ,285 bp product size for
Figure 1. Pre-treatment of MDCK cells with purified NanI enhances ETX binding and cytotoxicity. Panel A, cytotoxicity assay of MDCK
cells pretreated for the specified times with either 0.001 U/ml or 0.005 U/ml of NanI sialidase and then challenged with 5 mg/ml of purified ETX. Panel
B, AF488-pETX binding following the specified sialidase pre-treatment of MDCK cells. AF488-pETX (5 mg/ml) binding to MDCK cells in the absence of
any pre-treatment with sialidase was considered 100% binding. Panel C, pre-treatment with purified NanI sialidase enhances AF488-ETX complex
formation in, MDCK cells. Lane 1, sialidase and trypsin controls; Lane 2-4, ETX complex formation after sialidase pre-treatment of MDCK cells for 30, 60
or 90 min, followed by treatment with 5 mg/ml of AF488-ETX. Lane 5, ETX complex formation by 5 mg/ml AF488-ETX-treated MDCK cells (no sialidase
pretreatment); Molecular weight markers shown on the right. Panel D, quantitative comparison of the effects of NanI pretreatment on AF488-ETX
complex formation. Gel regions from panel C experiments containing the ETX complex were scanned for fluorescence using a Typhoon scanner. The
results shown in Figure 1 show the average of two (panel D) or three (panel A and B) repetitions; the error bars indicate the standard deviation (S.D.).
doi:10.1371/journal.ppat.1002429.g001
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PCR amplified larger bands for all three sialidase ORFs (data not
shown).
After curing the intron delivery plasmids from the BMC201,
BMC202, BMC203, BMC204 or BMC205 sialidase null mutants,
DNA from the wild-type strain and each null mutant was
subjected to Southern blot analysis (Figure 3A) using an intron-
specific probe [25]. No probe hybridization to wild-type DNA was
detected, as expected. In contrast, the presence of a single intron
insertion was visible on this Southern blot using DNA from each
single sialidase null mutant. In addition, two intron insertions were
detected using DNA from the BMC204 nanI/J double null mutant
and three intron insertions were noted using DNA from the
BMC205 nanI/J/H triple null mutant.
Phenotypic characterization of wild-type CN3718 and
isogenic sialidase null mutants
To initiate a phenotypic characterization, vegetative growth of
the isogenic mutants was compared in Todd Hewitt (TH) medium.
After similar inoculation into TH medium, the vegetative growth
rate of the isogenic mutants was nearly identical to the CN3718
parent (data not shown). Western blots then compared sialidase
expression between CN3718 and the isogenic single, double and
triple sialidase null mutants. These analyses demonstrated that
sonicated 8 h TH cultures of the wild-type strain contain the
129 kDa NanJ, the 77 kDa NanI and the 43 kDa NanH
(Figure 3B). In contrast, the BMC201 null mutant only produced
NanI and NanH, the BMC202 null mutant only produced NanJ
and NanH, and the BMC203 null mutant produced only NanI
and NanJ (Figure 3B). Similar Western blotting of sonicated
cultures (Figure 3C) showed that the BMC204 nanI/J double null
mutant only produced the 43 kDa NanH, while the BMC205
nanJ/I/H triple null mutant did not produce any sialidase protein.
To evaluate the effects of mutating each sialidase gene on the
total sialidase activity of CN3718, sialidase activity assays were
carried out using either 8 h TH culture supernatants (to measure
exosialidase activity) or sonicated 8 h TH culture supernatants (to
measure total sialidase activity) from the wild-type parent and each
null mutant strain. Collectively, the results (Figure 3D) indicated
that the exosialidase activity measured in supernatants from the
wild-type strain is mainly attributable to NanI. The Figure 3D
results also confirmed that NanH predominantly accumulates in
the cytoplasm since 8 h supernatants of the BMC204 nanI/J
double mutant exhibited almost no sialidase activity, while the
sonicated culture supernatant of this double mutant possessed
significant sialidase activity. Lastly, this analysis demonstrated that
CN3718 produces only the three recognized sialidases since the
supernatant and sonicated culture of the BMC205 nanI/J/H triple
null mutant lacked sialidase activity.
Since a major goal of the current study was to evaluate a
possible relationship between sialidases and ETX action, ETX
expression was measured for wild-type CN3718 and the isogenic
sialidase null mutants. Surprisingly, each single sialidase mutant,
but especially the BMC202 nanI null mutant, showed decreased
ETX expression compared to the wild-type parent (Figure 3E and
3F). ETX expression levels by the BMC204 nanI/J double null
mutant and the BMC205 nanI/J/H triple mutant decreased
further compared against ETX production levels by wild-type
CN3718 (Figure 3E and 3F).
Construction and genotypic characterization of isogenic
etx null mutants of CN3718 and BMC205
The considerable ETX expression differences between wild-
type strain CN3718 and the sialidase mutants shown in Figure 3E
and 3F precluded using those strains for comparative ETX
cytotoxicity experiments aimed at evaluating sialidase contribu-
tions to ETX action under natural sialidase expression levels and
in the presence of natural levels of other secreted C. perfringens
products. To overcome this complication, etx null mutations were
engineered into the CN3718 wild-type strain and the BMC205
triple sialidase null mutant strain to create BMC206 and
BMC207, respectively. The availability of these two etx mutants
would allow later comparative cytotoxicity experiments using
equivalent amounts of ETX added to supernatants of these strains.
These etx mutants were constructed by a Targetron insertional
mutagenesis approach. PCR confirmed the presence of an intron
Figure 2. Sialidase activity in different type C. perfringens strains. Sialidase activity was measured in supernatants from overnight and 6 h TH
cultures of the specified C. perfringens strains, including type A strains F4969, F5603, SM101and Strain13; type B strains CN1795 and NCTC8533; type C
strains CN3685 and CN5385 and type D strains CN2068, CN3718, CN3842, JGS1240, JGS4138 and CN8346. Results shown are the average of three
repetitions; the error bars indicate the standard deviation (S.D.). The origin and typing of these strains has been described previously [14,16,33-36].
doi:10.1371/journal.ppat.1002429.g002
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CN3718, internal etx PCR primers specifically amplified a PCR
product of 117 bp. However, consistent with a 900 bp intron
insertion into the etx ORF, the same primers amplified a PCR
product of ,1000 bp using DNA from the putative etx mutants of
both BMC206 and BMC207. PCR approaches also confirmed
that BMC207 maintains intron insertions in its nanI, nanJ and
nanH ORFs (Figure 4B).
After curing the intron delivery plasmids from these mutants,
DNA was isolated from the two putative etx null mutants and
subjected to Southern blotting using an intron-specific probe
(Figure 4C). This analysis detected no probe hybridization with
wild-type CN3718 DNA, as expected. As no suitable enzyme was
identified that could separate the four intron copies present in
BMC207, EcoRI was used to distinguish the presence of the etx
intron from the other three sialidase introns, whose presence in
the BMC205 mutant had already been demonstrated (Figure 3A).
By this approach, the presence of the etx intron was clearly
shown in BMC206 and BMC207 by Southern blotting
(Figure 4C).
Phenotypic characterization of isogenic BMC206 and
BMC207 null mutants
To initiate phenotypic comparisons, the growth rates of the
BMC206 and BMC207 etx null mutants were first determined to
be similar to wild-type CN3718 in TH medium (data not shown).
Western blotting then confirmed the lack of ETX expression by
these etx null mutants (Figure 4D). For later experiments it was
important to demonstrate that culture supernatants could be
Figure 3. Intron-based mutagenesis to create isogenic CN3718 sialidase null mutants and characterization of those mutants. Panel
A, Southern blot hybridization of an intron-specific probe with DNA from wild-type CN3718 or the sialidase null mutants (BMC201, BMC202, BMC203,
BMC204 or BMC205). DNA from each strain was digested with BsrGI and electrophoresed on a 1% agarose gel prior to blotting and hybridization with
an intron-specific probe. Size of DNA fragments, in kilobases (kb) is shown at left. Panel B, Western blot analyses for sialidase expression by wild-type
CN3718 or the nanJ, nanI or nanH single null mutants named BMC201, BMC202, or BMC203, respectively. Size of proteins in kDa is shown at right.
Panel C, Western blot analyses for sialidase expression by wild-type CN3718, the nanJ/nanI double null mutant (BMC204) or the nanJ/nanI/nanH triple
null mutant (BMC205). Size of proteins in kDa is shown at right. Panel D, sialidase activity analyses for wild-type CN3718 or specified sialidase null
mutant strains using 8 h TH culture supernatants or supernatants from 8 h TH sonicated cultures. Panel E, Western blot analyses for ETX expression
by wild type CN3718 or sialidase single, double or triple null mutant strains (BMC201, BMC202, BMC203, BMC204 or BMC205). Size of prototoxin in
kDa is shown at left. Panel F, Measurement of ETX expression by wild-type CN3718 or sialidase null mutant strains, based upon densitometric
scanning of panel E gels. All the results show the average of three repetitions; the error bars indicate the standard deviation (S.D.).
doi:10.1371/journal.ppat.1002429.g003
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levels. This was confirmed by adding 1, 5 or 10 mg/ml of ETX to
supernatants of the two etx null mutants (Figure 4D).
Sialidase Western blotting and sialidase activity analyses
(Figure 4E and 4F) were next performed using cultures or
sonicated cultures (to release NanH) of wild-type CN3718,
BMC206 and BMC207 to evaluate whether introducing an etx
gene mutation had affected sialidase expression. Western blot
results demonstrated comparable levels of NanJ, NanI and NanH
production by wild-type CN3718 and BMC206 when grown for
8 h in TH. However, as expected, production of these three
sialidases was absent from similar cultures of BMC207 (Figure 4E).
Measurement of sialidase activity in sonicated cultures (Figure 4F)
further confirmed those Western blotting results. The sialidase
activity detected in TH sonicated lysates or TH culture
supernatants of CN3718 vs. BMC206 was very similar. However,
no sialidase activity was measured in similarly prepared BMC207
sonicated lysates or culture supernatants.
Construction and characterization of nanJ, nanI and nanH
complementing strains of BMC207
For preparing a nanI complementing strain of BMC207, we first
constructed pJIR750Icomp, which consists of the CN3718 nanI
ORF, 500 bp of upstream sequence and 300 bp of downstream
sequence cloned into the C. perfringens/E. coli shuttle plasmid
pJIR750. A nanJ complementing plasmid, named pJIR751Jcomp,
was similarly prepared by PCR-amplifying a product correspond-
ing to the nanJ ORF, 1000 bp of upstream sequence and 400 bp of
downstream sequence, and then cloning that PCR product into
the C. perfringens/E. coli shuttle plasmid pJIR751. Finally, by the
same method, a nanH complementing plasmid named pJIR751H-
comp was prepared that contains 500 bp of upstream sequence,
the nanH ORF and 300 bp of downstream sequence cloned into
pJIR751. The three sialidase complementing plasmids were then
individually transformed into BMC207 by electroporation. PCR
confirmed the resultant transformants contained nanI, nanJ or
nanH wild-type genes (Figure 5A). Using primers to internal
Figure 4. Intron-based mutagenesis to create etx null mutants of wild-type CN3718 and BMC205. Panel A, PCR confirmation of
construction of isogenic etx null mutants of wild-type CN3718 (creating BMC206) and BMC205 (creating BMC207). Using DNA isolated from wild-type
CN3718, a PCR assay amplified a 117 bp product using internal etx primers but an ,1.0 kb product, consistent with insertion of a 0.9 kb intron, using
template DNA isolated from BMC206 or BMC207 etx null mutants. Lane 1, 100 bp molecular size markers. Panel B, PCR assays for nanI, nanJ or nanH
confirming that BMC206 carries the wild-type nanI, nanJ or nanH genes, but BMC207 has a 0.9 kb intron insertions in its nanI, nanJ and nanH null
mutant genes. Lane 1, 100 bp molecular size markers. Panel C, Southern blot hybridization of an intron-specific probe with DNA from wild-type
CN3718, BMC202, BMC204, BM205, BMC206 or BMC207. DNA from each strain was digested with EcoRI and electrophoresed on a 1% agarose gel
prior to blotting and hybridization with an intron-specific probe. Size of DNA fragments, in kilobases (kb), is shown at left. Panel D, ETX Western blot
analyses of supernatants from wild-type CN3718 or the BMC206 and BMC207 etx null mutants, without or with supplementation with 1 mg/ml, 5 mg/
ml or 10 mg/ml of ETX. Size of prototoxin in kDa is shown at left. Panel E, Western blot analyses for sialidase expression by wild-type CN3718, BMC206
or BMC207. Size of proteins in kDa is shown at right. Panel F, sialidase activity analyses for wild-type CN3718 or the BMC206 and BMC207 etx null
mutant strains using 8 h TH culture supernatants or supernatants from sonicated 8 h TH cultures.
doi:10.1371/journal.ppat.1002429.g004
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nanJ or nanH PCR products amplified large bands indicating an
intron insertion. In contrast, using DNA from the three
complementing strains, the PCR products amplified were of
smaller size, consistent with their containing a wild-type sialidase
gene, which is preferentially amplified over the larger intron-
disrupted sialidase gene also present in these complementing
strains.
Western blot analyses then assessed sialidase expression by the
complementing strains (Figure 5B). As expected, BMC206
produced the ,43 kDa NanH, the ,77 kDa NanI and the
,130 kDa NanJ. In contrast, the BMC207 null mutant expressed
no sialidase proteins. These Western blots also showed that the
nanH complementing strain BMC2073 only produced NanH, the
nanI complementing strain BMC2072 only made NanI, and the
nanJ complementing strain BMC2071 only expressed NanJ
(Figure 5B).
The sialidase activity of the complementing strains was also
assessed (Figure 5C). When sialidase activity was measured in 2 h,
4 h, 6 h, 8 h, 10 h or overnight TH cultures, the nanI
complementing strain BMC2072 started expressing NanI as early
as 2 h in TH culture. In contrast, BMC206 and the nanJ
complementing strain began producing sialidase at 4 h. Wild-type
CN3718 also expressed sialidase starting at 4 h (data not shown).
The NanI complementing strain BMC2072 produced more
sialidase activity than other complementing strains. Since the
BMC2072 nanI single complementing strain already expressed
more sialidase activity than either CN3718 or BMC206, and also
due to technical limitations, no double or triple sialidase
complementing strains were prepared.
Figure 5. Characterization of sialidase complementing strains. Panel A, PCR confirmation of the construction of isogenic sialidase null mutant
and complementing strains. Using DNA isolated from BMC206, PCR assays using internal sialidase gene primers amplified the expected wild-type
nanJ, nanI and nanH products of 306 bp, 467 bp and 285 bp, respectively. Using template DNA isolated from BMC207, which has a 900 bp intron
insertion in each sialidase gene, the same PCR assays amplified larger products of 1206 bp, 1367 and 1185 for nanJ, nanI and nanH, respectively. With
the same assay, DNA from each complementing strain yielded the same wild-type sized PCR products as amplified from BMC206. Lines 1 and 11,
100 bp or 1 kb molecular weight markers, respectively. Panel B, Western blot analyses for sialidase expression by complementing strains BMC2071
(for nanJ complementation), BMC2072 (for nanI complementation) and BMC2073 (for nanH complementation) using 8 h TH sonicated cultures. Size
of protein in kDa is shown at right. Panel C, sialidase activity detected in supernatants of BMC206, BMC207, BMC2071, BMC2072 or BMC2073 after
growth in TH medium for 2 h, 4 h, 6 h, 8 h, 10 h or overnight.
doi:10.1371/journal.ppat.1002429.g005
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toxin binding to MDCK cells
The availability of sialidase mutants and complementing strains
allowed us to evaluate whether specific sialidases can enhance
ETX binding to MDCK cells at natural sialidase expression levels
and in the background of other secreted C. perfringens products.
The same 5 mg/ml amount of AF488-pETX was added to
concentrated supernatants from BMC206, the BMC207 triple
sialidase null mutant strain, or the three BMC207 sialidase
complementing strains (i.e. BMC2071, BMC2072 and
BMC2073). Note that, i) a natural 16 concentration of C.
perfringens culture supernatant was finally present in these MDCK
cell cultures, ii) a 5 mg/ml ETX concentration corresponds to a
typical natural supernatant concentration of this toxin for ETX-
producing C. perfringens strains [5,6] and iii) these binding
experiments were performed at 37uC to obtain the enzymatic
effects of sialidases (when present), but previous studies [13] have
shown that prototoxin binding to MDCK cells is equivalent at 4uC
or 37uC.
When these mixtures were added to MDCK cells, the
fluorescent readings showed that the BMC207 supernatant sample
supported less AF488-pETX binding to MDCK cells compared
against the BMC206 supernatant (Figure 6). Supernatant from the
BMC2072 nanI complementing strain exhibited even greater levels
of AF488-pETX binding than did BMC206 supernatant after a
similar supplementation with the labeled prototoxin. In contrast, a
smaller increase in AF488-pETX binding was noted using
supernatants of the nanJ or nanH complementing strains
supplemented with labeled prototoxin.
NanI enhances epsilon toxin-mediated cytotoxicity in
MDCK cells
Figure 1 results demonstrated that pretreating MDCK cells with
purified C. perfringens NanI sialidase increases subsequent ETX
cytotoxicity. Results shown in Figure 7A confirmed this conclusion
and demonstrated that this effect is not due to direct sialidase-
induced cytotoxicity.
The Figure 6 binding results suggested that, compared against
supernatants from BMC207, increased MDCK cell cytotoxicity
should also be observed using supernatants from BMC206 or the
nanI complementing strain BMC2072 when those supernatants
were supplemented with ETX. Verifying this suggestion, the
ETX-supplemented culture supernatants of BMC206 strain
caused about 30% more MDCK cell cytotoxicity than did
similarly ETX-supplemented BMC207 supernatants (Figure 7B).
Furthermore, complementation with the wild-type nanI gene
substantially increased the cytotoxic effects of the sialidase-
deficient BMC207 mutant, while complementation of the
BMC207 mutant with the wild-type nanJ or nanH genes increased
cytotoxicity to a lesser extent.
NanI can be activated by trypsin
During natural disease, ETX is secreted into the animal
intestines as an inactive prototoxin of ,33 kDa, which can then
be activated by intestinal proteases such as trypsin or chymotrypsin
[11]. Interestingly, when CN3718 wild-type supernatants were
trypsin-treated to activate prototoxin (data not shown), overall
sialidase activity in these supernatants also significantly increased.
This result was confirmed by treating purified C. perfringens NanI
with trypsin. As shown in Figure 8A, the trypsin-treated NanI
possessed significantly increased sialidase activity compared
against the same amount of non-trypsin-treated NanI. When
these samples were subjected to Western blotting, the results
indicated that most of the trypsin-treated NanI ran as a slightly
smaller protein than native NanI, supporting proteolytic process-
ing (Figure 8B). In addition, chymotrypsin also activated NanI
sialidase activity (data not shown).
Trypsin activation of NanI can enhance cytotoxicity
A further experiment then compared ETX cytotoxicity in the
presence of purified NanI sialidase that had, or had not, been
trypsin-activated prior to mixing with purified active ETX. After
blocking trypsin activity from the sialidase sample with trypsin
inhibitor, an enhancement of ETX cytotoxicity was observed
using the trypsin-activated sialidase compared against the same
amount of sialidase that had not been trypsin-activated (Figure 9A).
Trypsin-activated sialidase alone caused no increase in cytotoxicity
above background.
Similar experiments using concentrated C. perfringens culture
supernatants showed that trypsin activation of these supernatants
enhanced MDCK cell cytotoxicity by about 25% for BMC206
(Figure 9B). Further supporting the involvement of sialidases in
this trypsin-induced increase in the cytotoxic properties of
BMC206, similar trypsin treatment of BMC207 supernatants did
not increase ETX-induced cytotoxicity (Figure 9B).
The Figure 8A results indicated that NanI can be activated by
trypsin. To assess whether the other two C. perfringens sialidase
(NanJ and NanH) can also be trypsin-activated, the supernatants
of nanI, nanJ and nanH complementing strains were similarly
treated with trypsin and their sialidase activity was measured.
The results obtained indicated that only the sialidase activity of
NanI is enhanced by trypsin (Figure 10A). In contrast, NanJ and
NanH sialidase activity slightly decreased after similar trypsin
treatment (Figure 10A). Consistent with this result, trypsin
increased the MDCK cell cytotoxicity of supernatants containing
only NanI, but not supernatants containing only NanJ or NanH
(Figure 10B).
Figure 6. Binding of the Alex 488-labeled prototoxin to MDCK
cells. The left bar shows fluorescence for a negative control sample
using MDCK cells lysed with RIPA buffer but not treated with labeled
prototoxin. Another control shown included fluorescence for MDCK
cells treated only with labeled prototoxin binding (no C. perfringens
culture supernatant added). BMC206, BMC207, BMC2071, BMC2072,
BMC2073 samples show fluorescence measured when labeled proto-
toxin (5 mg/ml) was added to the indicated TH supernatant before
MDCK cell treatment. The results show the average of three repetitions;
the error bars indicate standard errors of the means.
doi:10.1371/journal.ppat.1002429.g006
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PLoS Pathogens | www.plospathogens.org 8 December 2011 | Volume 7 | Issue 12 | e1002429Figure 7. Sialidases increase cytotoxicity for MDCK cells. Panel A, percent of dead MDCK cells after treatment at 37uC for 1 h with 5 mg/ml
ETX, 5 mg/ml pETX, 0.005 U/ml NanI sialidase or a mixture of 5 mg/ml ETX and 0.005 U/ml NanI sialidase, Panel B, percent of dead MDCK cells after the
cells were treated for 1 h at 37uC with 5 mg/ml of ETX dissolved in BMC206, BMC207, BMC2071, BMC2072 or BMC2073 culture supernatants. BMC206
and BMC207 culture supernatants without ETX supplementation are shown for comparison. The results shown represent the average of three
repetitions; the error bars indicate standard errors of the means.
doi:10.1371/journal.ppat.1002429.g007
Figure 8. Effects of trypsin treatment on NanI sialidase. Panel A, Sialidase enzymatic activity was measured for 0.005 U/ml of purified NanI
sialidase or 0.005 U/ml of purified NanI sialidase that had been treated for 1 h with 15 mg/ml of trypsin (note: following this treatment, trypsin activity
was blocked using trypsin inhibitor). Also shown is sialidase activity measured for 15 mg/ml of trypsin (with trypsin inhibitor but no NanI sialidase
added) and the buffer control. The results shown represent the average of three representations; the error bars indicate standard errors of the means.
Panel B, Western blot comparative size analysis of NanI sialidase and trypsin-treated NanI sialidase. Size of protein in kDa is shown at left.
doi:10.1371/journal.ppat.1002429.g008
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CN3718 exosialidase activity
During natural enterotoxemias, type D strains remain present in
the intestines, where they contact host enterocytes [8]. Therefore,
an experiment examined whether contact with cultured mamma-
lian cells for 6 hr (including intestinal Caco-2 and HT-29 cells as
well as MDCK, Vero and NT6 fibroblasts) might affect the
exosialidase activity of BMC206. This study revealed that contact
between BMC206 and Caco-2, HT-29, or MDCK cells resulted in
increased culture supernatant sialidase activity, although this effect
was weaker using MDCK cells. In the absence of BMC206
infection, supernatant sialidase activity for Caco-2, HT-29 and
MDCK cell cultures did not increase above background
(Figure 11A), suggesting that the increased culture supernatant
sialidase activity measured in the BMC206-infected cultures was
not from secreted mammalian sialidase activity. The results also
detected no culture supernatant sialidase activity upon infection of
these mammalian cells with the triple sialidase null mutant
BMC207. In contrast to the stimulation of sialidase activity
observed using Caco-2, HT-29 or MDCK cells, exosialidase
activity did not increase after BMC206 infection of Vero cell or
NT6 fibroblast cultures (Figure 11A).
The nature of this host cell-induced increase in sialidase
activity was further investigated using a Caco-2 cell infection
model (Figure 11B). This study detected no culture supernatant
sialidase activity upon infection of the triple null mutant BMC207
with Caco-2 cells up to 6 h, consistent with the increased sialidase
activity detected upon BMC206 infection of Caco-2 cells
involving upregulated sialidase expression by BMC206 upon
Caco-2 cell contact. Results obtained using the BMC2072 NanI
complementing strain suggested this upregulation of sialidase
Figure 9. Trypsin-activation of NanI sialidase further enhances ETX-induced MDCK cell cytotoxicity. Panel A, percent of dead MDCK
cells after treatment for 1 h at 37uC with 5 mg/ml of ETX in the presence of 0.005 U/ml sialidase or 5 mg/ml ETX in the presence of trypsin-treated
0.005 U NanI sialidase (note that trypsin activity in this sample was blocked with trypsin inhibitor before it was added to MDCK cells). Controls shown
include: Prototoxin, NanI (no ETX), the trypsin and trypsin inhibitor mixture (no ETX or sialidase), and NanI with trypsin/trypsin inhibitor (no ETX). The
results shown represent the average of three repetitions; the error bars indicate standard errors of the means. Panel B, percent of dead MDCK cells
after treatment for with 5 mg/ml of ETX dissolved in BMC206 or BMC207 supernatants that had or had not been trypsin-treated for 1 h at 37uC (note:
after this treatment, trypsin activity in this sample was blocked using trypsin inhibitor before the sample was added to MDCK cells). Effects of trypsin-
treated BMC206 or BMC207 supernatants (no ETX addition) are shown as controls. The results shown represent the average of three repetitions; the
error bars indicate standard errors of the means.
doi:10.1371/journal.ppat.1002429.g009
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involves increased NanI production (Figure 11B). To definitively
resolve whether contact with Caco-2 cells upregulates NanI
expression by BMC206, quantitative RT-PCR studies were
performed (Figure 11C). Those studies clearly demonstrated a
substantial increase in nanI transcription in the presence of Caco-
2 cells.
NanI increases C. perfringens attachment to some
mammalian cells
When causing disease originating in the intestines, C. perfringens
type D vegetative cells likely adhere to intestinal tissue to colonize
and sustain toxin production [8]. Relatively little is known about
C. perfringens adherence to host cells, particularly enterocytes during
enteritis or enterotoxemia. However, since enterocytes are coated
with a variety of sialic acid-containing glycoconjugates, sialic acid
residues could conceivably modulate attachment of these bacteria
to the intestines.
Therefore, experiments tested whether BMC206 or BMC207
can attach to cultured mammalian cells, including Caco-2 cells,
HT-29 cells, MDCK cells, Vero cells and NT6 fibroblasts. As
shown in Figure 12A and 12B, BMC206 attached well to Caco-2
and HT-29 cells, but substantially less well to the other surveyed
host cells. BMC206 attachment to Caco-2 and HT-29 cells
involved sialidase production since BMC207 failed to attach to
those two mammalian cell lines (Figure 12A and 12B).
Additional studies were performed with the human enterocyte-
like Caco-2 cell line as an in vitro model to examine whether
Figure 10. Sialidase activity and cytotoxicity for MDCK cells caused by culture supernatants from complementing strains. Panel A,
sialidase activity detected in 8 h TH culture supernatants with or without trypsin treatment (note: following trypsin treatment, trypsin activity was
blocked with trypsin inhibitor before the sample was assayed for sialidase activity). Effects of BMC207 and trypsin-treated BMC207 8 h TH culture
supernatants are shown as controls. The results shown represent the average of three repetitions; the error bars indicate standard errors of the
means. Panel B, percent of dead MDCK cells after treatment for 1 h at 37uC with 5 mg/ml of ETX added to 8 h TH culture supernatants of BMC2071,
BMC2072 or BMC2073; % dead MDCK cells after treatment for 1 h with 5 mg/ml of ETX added to 8 h trypsin-treated TH culture supernatants of
BMC2071, BMC2072 or BMC2073 (after this treatment, trypsin activity was blocked with trypsin inhibitor before addition of the sample to MDCK cells).
Also shown are the cytotoxic effects after 1 h on MDCK cells of BMC2071, BMC2072 or BMC2073 8 h TH culture supernatants without ETX
supplementation, as well as trypsin treated BMC2071, BMC2072 or BMC2073 8 h TH culture supernatants without ETX supplementation. The results
shown represent the average of three repetitions; the error bars indicate standard errors of the means.
doi:10.1371/journal.ppat.1002429.g010
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(Figure 13A and 13B). As already established (Figure 12A),
BMC206 attached well to Caco-2 cells. In contrast, there was little
or no attachment of BMC207 to these host cells under the same
experimental conditions. However, the BMC2072 nanI comple-
menting strain exhibited Caco-2 cell adhesion levels equal to, or
exceeding those of, BMC206 (Figure 13A and 13B). In contrast,
the Caco-2 adhesion ability of the nanJ and nanH complementing
strains was not substantially increased over the attachment of
BMC207 (Figure 13A and 13B).
A role for NanI sialidase in modifying the Caco-2 cell surface to
increase the adherence of CN3718 vegetative cells to these host
cells was further supported by results of an experiment where
Caco-2 cells were pretreated with purified NanI. This pretreat-
ment substantially increased the Caco-2 cell adherence of the
BMC207 mutant (data not shown).
Phase-contrast and immunofluorescence microscopy analyses
(Figure 13C) confirmed the strong adhesion of BMC206 or
BMC2072 vegetative cells to Caco-2 cells. This microscopy
detected many adherent bacteria attached to Caco-2 cells, often
along their edges. In contrast, few (if any) BMC207 cells were
adherent to Caco-2 cells.
Discussion
A recent study [20] showed that a nanI mutation nearly
completely abolished the sialidase activity of C. perfringens type A
strain 13, which produces NanI and NanJ. However, unlike strain
13, many C. perfringens strains can also produce NanH [14]. Using
a combination of nanI, nanJ or nanH single null mutants, a nanI/
nanJ double null mutant, and a sialidases triple null mutant, the
current study evaluated the relative contribution of each sialidase
Figure 11. Sialidase activity upon contact with mammalian cells. Panel A, Sialidase activity detected after washed BMC206 and BMC207 cells
were suspended in HBSS and added to tissue culture wells that did or did not contain monolayers of HT-29, MDCK, Caco-2, NT6 or Vero cells. Buffer
w/o cells as negative control. The results show average of three representations; the error bars indicate standard errors of the means. Panel B,
Sialidase activity detected after washed BMC206, BMC207, BMC2071 or BMC2072 cells were suspended in HBSS and added to tissue culture wells that
did or did not contain monolayers of Caco-2 cells for 2, 4 or 6 h. The results shown represent the average of three repetitions; the error bars indicate
standard errors of the means. Panel C, Real time PCR for sialidase gene mRNA expression (nanJ, nanI and nanH), when the washed bacteria were
added to tissue culture wells that did or did not contain Caco-2 cells, followed by incubation for 2, 4 or 6 h. The results show the average of three
representations; the error bars indicate standard errors of the means.
doi:10.1371/journal.ppat.1002429.g011
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perfringens type D strain CN3718. These analyses revealed that,
using the sialidase assay conditions employed in this study, i)
CN3718 produces all three recognized C. perfringens sialidases but
no additional unknown sialidases, ii) NanI is responsible for most
exosialidase activity of this strain and iii) NanH is also a major
contributor to the total sialidase activity possessed by CN3718.
Furthermore, by demonstrating that CN3718 produces all three
sialidases, the current results argue against proposals [17] that only
myonecrosis strains of C. perfringens produce all three sialidases.
Bioinformatics analyses of database sequences support carriage of
three sialidase genes as the norm for C. perfringens strains, regardless
of origin. In addition to our current CN3718 findings, analysis of
the 8 completed or partially-completed C. perfringens genomes
revealed that all three sialidase genes are present in 6 of those 8
isolates, which include several isolates from humans or livestock
suffering from C. perfringens disease originating in the intestines.
The two exceptions are strain 13 and SM101 that, respectively,
lack nanH or both nanI and nanJ [14,16].
Previous studies with other bacterial pathogens showed that
sialidases can contribute to virulence in several ways, e.g., by
exposing sites to facilitate more bacterial adhesion or toxin
binding to host cells [19,26]. Our results indicated that NanI
sialidase increases the ETX sensitivity of MDCK cells. The
mechanism of this enhancement was shown, for the first time, to
involve an increase in toxin binding, suggesting NanI exposes
additional ETX receptors on the host cell surface. Alternatively,
NanI could modify host cell surface nonreceptors so they acquire
ETX binding ability, similar to the situation in Vibrio cholerae,
where a sialidase modifies glycolipids to increase cholera toxin
binding [18]. We also demonstrated that increased ETX binding
to NanI-exposed MDCK cells leads to more ETX complex
Figure 12. Attachment of C. perfringens to mammalian cells. Caco-2, HT-29, NT6, Vero or MDCK cells monolayers were incubated for 2 h with
the indicated bacteria at 37uC under anaerobic conditions. Monolayers were then washed three times with HBSS buffer, lysed in distilled water and
total bacteria were plated onto BHI agar plates for counting. Panel A, Attachment levels expressed as the percentage of attached bacteria relative to
the total number of input bacteria. The results shown represent the average of three repetitions; the error bars indicate standard errors of the means.
Panel B, Attachment levels expressed as the bacteria attached per mammalian cell. The results shown represent the average of three repetitions; the
error bars indicate standard errors of the means.
doi:10.1371/journal.ppat.1002429.g012
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cell death [23]. Overall, these conclusions are consistent with,
and explain for the first time, observations from a previous study
reporting that C. perfringens sialidases can increase ETX
cytotoxicity towards MDCK cells [21]. They are also consistent
with previous results showing that soluble sialic acid cannot
inhibit ETX binding to, or action on, MDCK cells [21].
However, the current results apparently contrast with another
study [22] reporting that sialidases lower ETX binding to brain
synaptosomal membrane vesicles. It is not immediately clear
whether the varying conclusions amongst these studies are
attributable to using MDCK cells vs. synaptosomal membranes
or involve some other explanation.
Sialidases assist the ability of some pathogens to adhere to host
cells or tissues. For example, sialidase contributions to adherence
and colonization are well-documented for S. pneumoniae [19].
However, prior to the current work, only one study had addressed
C. perfringens vegetative cell adherence to the mammalian intestinal
epithelium, despite the likely importance of this process for
pathogenesis; that earlier study suggested a putative C. perfringens
collagen adhesion protein (CNA) might contribute to porcine
enteritis by promoting adhesion of this bacterium to damaged
Figure 13. Attachment of C. perfringens to Caco-2 cells. Caco-2 cell monolayers were incubated for 2 h with bacteria at 37uC under anaerobic
conditions. Monolayers were then washed three times with HBSS buffer, lysed in distilled water and total bacteria were plated onto BHI agar plates
for counting. Panel A, Attachment levels expressed as the percentage of attached bacteria relative to the total number of input bacteria. The results
shown represent the average of three repetitions; the error bars indicate standard errors of the means. Panel B, Attachment levels expressed as the
bacteria attached per mammalian cell. The results shown represent the average of three repetitions; the error bars indicate standard errors of the
means. Panel C, C. perfringens BMC206, BMC207 and BMC2072 attached to Caco-2 cells as detected by fluorescence microscopy (6006) as described
in the Materials and Methods. Green: bacteria; Red: Caco-2 cells.
doi:10.1371/journal.ppat.1002429.g013
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adherence of a C. perfringens strain to certain host cells, including
enterocyte-like Caco-2 cells, is facilitated by sialidases, especially
NanI. Inactivation of NanI sialidase production decreased
adhesion of CN3718 strain by at least 20-fold and this effect was
reversible by complementation. Furthermore, pretreating Caco-2
cells with purified NanI allowed adherence of the BMC207
mutant unable to produce any sialidase, indicating that NanI
modifies the Caco-2 cell surface to render it favorable for CN3718
adherence. NanH and NanJ appeared to play a lesser role in
facilitating C. perfringens adherence to Caco-2 cells based upon
complementation results using the triple sialidase mutant. The
varying ability of the three sialidases to enhance ETX binding or
C. perfringens adherence likely reflects the reported enzymatic
difference in sialidase kinetic properties and substrate specificities
[17], although further comparative study of the properties of C.
perfringens sialidases is warranted.
These in vitro findings open the possibility that sialidases,
particularly NanI, contribute to virulence by facilitating C.
perfringens adherence in the intestines, a hypothesis that should be
tested in animals. In addition, future studies should identify the
adhesins mediating CN3718 binding to certain host cells. Beyond
the CNA study [27] mentioned in the preceding paragraph, the
only other available information regarding molecular mechanisms
of C. perfringens adhesion to host cells is a report implicating type IV
pilin in type A strain 13 attachment to myoblasts [28]. Future
studies will examine whether the type IV pilus or CNA protein
contribute to CN3718 adherence to host cells.
A notable finding of the current work was that CN3718
adhesion is specific for certain mammalian cells. Notably, this
strain adheres well to Caco-2 and HT-29 cells, both of which are
intestinal cell lines. Much lower attachment of this strain was
detected using cell lines of nonintestinal origin, including MDCK
cells (canine kidney cells), Vero cells (African green monkey kidney
cells) or NT6 rat fibroblasts cells. Furthermore, contact of CN3718
with the intestinal cells lines, and MDCK cells to a lesser degree,
also stimulated nanI transcription. Collectively, these results
suggest that CN3718, a type D disease strain, is well-adapted for
sensing the presence of enterocytes and then responding by
producing more sialidase to facilitate its specific attachment to
these cells. However, a survey including many additional cell lines
and C. perfringens strains are needed to test this hypothesis.
The current study also suggests that trypsin could be a greater
contributor to type D disease than previously appreciated [29]. It
is well established that, following secretion, the inactive ETX
prototoxin must be activated by protease-induced removal of
residues from the N- and C-terminus [29]. This prototoxin
activation normally occurs in the gut of infected animals, where it
likely involves intestinal proteases, including trypsin. Interestingly,
the current study found that trypsin proteolytically activates NanI
as well as ETX, thereby increasing sialidase activity. Since we also
showed that trypsin activation of NanI enhances ETX binding and
cytotoxicity towards MDCK cells, trypsin-activated NanI could
similarly increase ETX action in vivo. Furthermore, since NanI was
also determined to be important for CN3718 adherence to Caco-2
cells, trypsin activation of NanI could also contribute to type D
disease by promoting C. perfringens colonization in the intestines.
Chymotrypsin also activated NanI sialidase activity (data not
shown), so that intestinal protease could further enhance disease.
Another possible virulence role for sialidases is suggested by our
observation that various CN3718 sialidase mutants, particularly nanI
mutants, exhibited significantly decreased ETX production levels
despite wild-typegrowthproperties (data not shown).Thisresult might
indicate that sialic acid signals ETX production, but initial attempts to
prove this hypothesis have yielded inconclusive results (data not
shown). Interestingly, previous studies showed that inactivating the
nanI gene in strain 13 also affects toxin production levels [20].
However, for that strain, the nanI mutant showed increased
production levels of alpha-toxin and perfringolysin O. Whether the
increased production of alpha toxin and perfringolysin O by strain 13
involves a sialic acid signal should also be evaluated in the future.
While our findings suggest NanI plays, at minimum, two
virulence roles for CN3718, i.e., enhancing both ETX binding and
attachment of this strain to enterocytes, it remains unclear why this
strain also produces NanJ and NanH sialidases. As mentioned,
NanH and NanI have different temperature optimums, kinetic
properties and substrate specificities [17]; the enzymatic charac-
teristics of NanJ, which was only discovered during genome
sequencing studies [14] remains uncharacterized. Possibly NanH
and NanJ are important for growth or survival in specific
environments such as soil or sewage or in other infections.
Furthermore, NanJ possesses additional domains of unknown
function that are missing from NanI [17]; those additional NanJ
domains might contribute to growth or virulence under conditions
that remain to be identified.
In summary, our in vitro results suggest that, while NanI sialidase
does not appear to be involved in the pathogenesis of type A
isolates during myonecrosis [20], it could contribute to type D
enterotoxaemia and enteritis in at least two ways. First, NanI
(particularly after trypsin activation in the intestines) could increase
ETX binding and complex formation, thereby potentiating ETX
cytotoxicity. The potential relevance of this effect for damage to
non-intestinal target organs, such as brain and kidneys, is unclear
since it has not yet been evaluated whether NanI sialidase can be
absorbed into the circulation during type D enterotoxemias.
Similarly, ETX causes limited damage in the intestines of sheep
[8], so sialidase potentiation of ETX may have less importance
during ovine type D disease. However, sialidases could possibly
increase ETX binding to the intestines of sheep or goats and thus
facilitate absorption of this toxin into the circulation. Moreover,
ETX does substantially damage the caprine gastrointestinal tract
[8,30], so, by enhancing ETX intestinal toxicity, trypsin-activated
NanI could directly contribute to caprine type D enteritis. A
second possible virulence contribution of NanI may be to increase
C. perfringens vegetative cell adherence to the intestinal epithelium,
thereby contributing to type D infections by facilitating coloniza-
tion of ETX-producing bacteria in the intestines. Lastly, our
results suggest that contact with intestinal cells may stimulate C.
perfringens to produce more NanI, thereby further potentiating
(particularly after trypsin and chymotrypsin activation) ETX
effects and bacterial adherence during disease. The relevance of
these in vitro findings for possible sialidase virulence contributions
should now be tested experimentally in animal models.
Materials and Methods
Bacterial strains and medium
CN3718, an ETX-positive C. perfringens type D animal disease
strain (Table 1), originated from the Burroughs-Wellcome
collection and was obtained via Dr. R. G. Wilkinson [5].
NCTC8346, another type D animal disease isolate, was used for
ETX toxin purification [5]. E.coli Top10 cells (Invitrogen) were
used as the cloning host. Mutant, complementing strains, and
plasmids used in this study are listed in Table 1.
Media used in this study for culturing C. perfringens included
FTG medium (fluid thioglycolate medium; Difco Laboratories);
TH medium (Bacto Todd Hewitt Broth [Becton-Dickinson], with
0.1% sodium thioglycolate [Sigma Aldrich]); TGY medium (3%
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ic], 1% yeast extract [Becton-Dickinson], and 0.1% sodium
thioglycolate [Sigma Aldrich]) and BHI agar plates (brain heart
infusion, Becton-Dickinson). For culturing E. coli, Luria-Bertani
(LB) broth (1% tryptone [Becton-Dickinson], 0.5% yeast extract
[Becton-Dickinson], 1% NaCl [Fisher scientific] and LB agar
(1.5% agar [Becton-Dickinson]) were used. All antibiotics used in
this study were purchased from the Sigma-Aldrich Chemical
Company or Fisher Scientific Company.
Proteins and antibodies
Purified C. perfringens neuraminidase (NanI) was purchased from
Roche Applied Science. ETX prototoxin was purified to homoge-
neity using a previously described method [5]. Following the method
described by the manufacturer, the purified ETX prototoxin was
fluorescently-labeled using an Alexa Fluor 488 protein labeling kit
(Invitrogen), creating AF488-pETX. For ETX detection by Western
blots, an ETX-specific monoclonal antibody (5B7; kindly provided
by Paul Hauer, Center for Veterinary Biologics, Ames, Iowa) was
used as primary antibody, followed by rabbit anti-mouse immuno-
globulin G (IgG)-peroxidase conjugate (Sigma) as a secondary
antibody. A polyclonal rabbit antibody against C. perfringens
neuraminidases was purchased from Thermo Scientific.
Construction of nanJ-, nanI- and nanH-null mutant of C.
perfringens CN3718
The nanJ, nanI and nanH genes of CN3718 were each
inactivated by insertion of a group II intron via the Clostridium-
modified TargeTron gene knock-out system [24]. Using intron
insertion sites identified by the Sigma TargeTron algorithm, an
,900 bp intron was targeted into the nanJ, nanI and nanH ORFs
in a sense orientation. The intron insertion was targeted between
nucleotides 657 and 658 of the nanJ ORF. The primers used for
PCR targeting the nanJ intron were 657/658-IBS, 657/658-
EBS1d and 657/658-EBS2 (Table 2). The intron insertion was
targeted between nucleotides 730 and 731 of the nanI ORF using
primers 730/731-IBS, 730/731-EBS1d and 730/731-EBS2
(Table 2). The intron insertion was targeted between nucleotides
707 and 708 of the nanH ORF. The primers used for PCR
targeting the intron into nanH were 707/708-IBS, 707/708-
EBS1d and 707/708-EBS2 (Table 2).
The 350 bp intron PCR products were inserted into pJIR750ai
between the HindIII and BsrGI enzyme sites in order to construct
nanJ, nanI and nanH-specific TargeTron mutagenesis plasmids.
The resultant plasmids, named pJIR750nanJi, pJIR750nanIi and
pJIR750nanHi respectively (Table 1), were individually electro-
porated into wild-type CN3718. This produced nanJ, nanI and
nanH single null mutants named, respectively, BMC201, BMC202
and BMC203 (Table 1).
The CN3718 transformation efficiency was ,240 transfor-
mants/mg plasmid DNA. Transformants were selected on BHI
agar plates containing 15 mg/ml of chloramphenicol. Transfor-
mant colonies were then identified by colony PCR using primers
nanJKOF and nanJKOR (Table 2) for screening nanJ-null
mutants (BMC201), primers nanIKOF and nanIKOR (Table 2)
for screening nanI-null mutants (BMC202), and primers nanH-
KOF and nanHKOR (Table 2) for screening nanH-null mutants
(BMC203). Each reaction mixture was subjected to the following
PCR amplification conditions: cycle 1, 95uC for 5 min; cycles 2
through 35, 95uC for 30 s, 55uC for 40 s, and 68uC for 90 s; and a
Table 1. Strains, mutants and plasmids used in this study.
Strain or plasmid Description Origin
Isolate name
CN3718 Wild type (etx
+, nanJ
+, nanI
+, nanH
+) Animal disease
BMC201 CN3718::nanJ This study
BMC202 CN3718::nanI This study
BMC203 CN3718::nanH This study
BMC204 CN3718::nanJ/nanI This study
BMC205 CN3718::nanJ/nanI/nanH This study
BMC206 CN3718::etx This study
BMC207 CN3718::nanJ/nanI/nanH/etx This study
BMC2071 BMC207+ pJIR751nanJ This study
BMC2072 BMC207+ pJIR750nanI This study
BMC2073 BMC207+ pJIR751nanH This study
Plasmid name
pJIR750 E.coli-C. perfringens shuttle vector Bannum and Rood [37]
pJIR751 E.coli-C. perfringens shuttle vector Bannum and Rood [37]
pJIR750nanJi pJIR750 with nanJ targeted intron This study
pJIR750nanIi pJIR750 with nanI targeted intron This study
pJIR750nanHi pJIR750 with nanH targeted intron This study
pJIR750etxi pJIR750 with etx targeted intron This study
pJIR751Jcomp pJIR751 with nanJ complementation fragment This study
pJIR750Icomp pJIR750 with nanI complementation fragment This study
pJIR751Hcomp pJIR751 with nanH complementation fragment This study
doi:10.1371/journal.ppat.1002429.t001
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sample was electrophoresed on a 1.5% agarose gel and then
visualized by staining with ethidium bromide. The mutants were
cured of the intron-carrying donor plasmid as described [25].
Construction of the CN3817 nanI/nanJ double null
mutant BMC204
To prepare a nanI/nanJ double null mutant, pJIR750nanJi was
electroporated into the BMC202 nanI null mutant strain, which
had been cured of the pJIR750nanIi plasmid. Transformants were
grown on BHI agar plates containing 15 mg/ml chloramphenicol
and putative nanJ/nanI double null mutants were then identified
by demonstrating the presence of introns in both the nanI and nanJ
ORFs by PCR. The confirmed nanI/nanJ double null mutant
(named BMC204, Table 1) was cured the intron-carrying donor
plasmid pJIR750nanJi. The identity of this BMC204 nanI/nanJ
double null mutant was then confirmed by Southern blotting,
which demonstrated the presence of two introns in the mutant.
Construction of the BMC205 nanI/nanJ/nanH triple null
mutant
To prepare a nanI/nanJ/nanH triple null mutant, pJIR750nanHi
was electroporated into the BMC205 double nanI/nanJ null mutant
strain and transformants were then grown on BHI agar plates
containing15 mg/mlofchloramphenicol.PutativenanHnullmutants
were screened by PCR, as described above. The presence of introns
in the nanI, nanJ and nanH genes of this mutant (named BMC205,
Table 1) was confirmed by PCR and Southern blotting, following
curing of the intron-carrying donor plasmid pJIR750nanHi.
Inactivation of the etx gene in CN3817 and BMC205
An intron insertion, with a sense orientation, was targeted
between nucleotides 330 and 331 of the etx ORF. The primers
used for targeting this intron were 330/331-IBS, 330/331-EBS1d
and 330/331-EBS2 (Table 2). The 350-bp PCR products were
inserted into pJIR750ai between the HindIII and BsrGI enzyme
sites in order to construct an etx-specific TargeTron plasmid. The
resultant plasmid, named pJIR750etxi (Table 1), was electropo-
rated into either wild-type CN3718 or BMC205 to inactivate their
etx genes, which produced (respectively) etx null mutant strains
named BMC206 and BMC207 (Table 1). The primers used for etx
null mutant scanning were etxkoF and etxkoR (Table 2).
Southern hybridization analyses
DNA was isolated from wild-type CN3718, the five sialidase null
mutants (including the three single null mutants BMC201, BMC202
Table 2. Primers used in this study.
Primer name Sequence (5’R3’) Purpose
657/658-IBS AAAAAAGCTTATAATTATCCTTAACTATCGTAACTGTGCGCCCAGATAGGGTG nanJ intron preparation
657/658-EBS1d CAGATTGTACAAATGTGGTGATAACAGATAAGTCGTAACTAGTAACTTACCTTTCTTTGT nanJ intron preparation
657/658-EBS2 TGAACGCAAGTTTCTAATTTCGATTATAGTTCGATAGAGGAAAGTGTCT nanJ intron preparation
730/731-IBS AAAAAAGCTTATAATTATCCTTAGTAAACACAGAGGTGCGCCCAGATAGGGTG nanI intron preparation
730/731-EBS1d CAGATTGTACAAATGTGGTGATAACAGATAAGTCACAGAGCCTAACTTACCTTTCTTTGT nanI intron preparation
730/731-EBS2 TGAACGCAAGTTTCTAATTTCGATTTTTACTCGATAGAGGAAAGTGTCT nanI intron preparation
707/708-IBS AAAAAAGCTTATAATTATCCTTAAAACACAGTTCCGTGCGCCCAGATAGGGTG nanH intron preparation
707/708-EBS1d CAGATTGTACAAATGTGGTGATAACAGATAAGTCAGTTCCTATAACTTACCTTTCTTTGT nanH intron preparation
707/708-EBS2 TGAACGCAAGTTTCTAATTTCGATTTGTTTTCGATAGAGGAAAGTGTCT nanH intron preparation
nanJKOF CTGCAATTCAAGGTGTTGGTG nanJ null mutant scanning and qRT-PCR
nanJKOR CTTGTCTTCTAAGCTCATATCC nanJ null mutant scanning and qRT-PCR
nanIKOF CAAGAGTTGGTTTTGAGC nanI null mutant scanning and qRT-PCR
nanIKOR AAATAAGGCTGGTATTCTG nanI null mutant scanning and qRT-PCR
nanHKOF AATTGGATGGCTAGGTGGAGTT nanH null mutant scanning and qRT-PCR
nanHKOR CAGGTGCTTCCTAAATCGTGAG nanH null mutant scanning and qRT-PCR
330/331-IBS AAAAAAGCTTATAATTATCCTTACCATCCATGAATGTGCGCCCAGATAGGGTG etx intron preparation
330/331-EBS1d CAGATTGTACAAATGTGGTGATAACAGATAAGTCATGAATTATAACTTACCTTTCTTTGT etx intron preparation
330/331-EBS2 TGAACGCAAGTTTCTAATTTCGGTTGATGGTCGATAGAGGAAAGTGTCT etx intron preparation
etxkoF GGTTACTATAAATCCACAAGGA etx null mutant scanning
etxkoR GTTAAGAGAGCTTTTCCAACAT etx null mutant scanning
nanJcomF CGGCggatccCAATAGACTTAGATGTTTTAGACCC (small letters show a BamHI site) nanJ complementation
nanJcomR GCAGgtcgacCTATCTCCTGGTCTAACATTTT (small letters show a SalI site) nanJ complementation
nanIcomF TAGAgtcgacACACCTTTAAGTTTTAAGAAA (small letters show a SalI site) nanI complementation
nanIcomR TAGCctgcagTTTTTATTACTACCCTCTGAAG (small letters show a PstI site) nanI complementation
nanHcomF CGGCggatccTTTATAATAATTCTAAGTCTCACC (small letters show a BamHI site) nanH complementation
nanHcomR GCAGgtcgacGAAAAGAGTCTGTCATTAGCAG (small letters show a SalI site) nanH complementation
16sF CGCATAACGTTGAAAGATGG qRT-PCR 16S rRNA house keeping gene
16sR CCTTGGTAGGCCGTTACCC qRT-PCR 16S rRNA house keeping gene
doi:10.1371/journal.ppat.1002429.t002
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and the triple sialidase null mutant strain BMC205) and the two etx
null mutants of CN3718 and BMC205 (including the BMC206 null
mutant that produces all three sialidases and the BMC207 null
mutant unable to produce any sialidase) using the MasterPure
TM
Gram-Positive DNA Purification Kit (Epicenter). Each DNA was
then digested with BsrGI or EcoRI overnight at 37uC and run on a
1% agarose gel. After the alkali transfer to a nylon membrane
(Roche), the blot was hybridized with a digoxigenin-labeled, intron-
specific probe as described previously [25]. This intron-specific
probewaspreparedusingtheprimersKO-IBSand KO-EBS1d[25]
and a PCR DIG Labeling Kit (Roche Applied Science) according to
the manufacturer’s instructions.
Complementation of the nanJ, nanI and nanH null
mutants
DNA was isolated from CN3718 using the Master Pure
TM
Gram-positive DNA purification kit. The primers nanJcomF and
nanJcomR (Table 2) were used for nanJ complementing strain
construction.The primersnanIcomF and nanIcomR (Table2) were
used for nanI complementing strain construction. The primers
nanHcomF and nanHcomR (Table 2) were used for construction of
a nanH complementing strain. The PCR reactions were set up as:
1 ml of each pair of primers (at a 0.5 mM final concentration), 1 mlo f
purified DNA template and 25 ml2 6Taq Long Range Mixture
(NEB) were mixed together and ddH2O was added to reach a total
volume of 50 ml. The reaction mixtures were then placed in a
thermal cycler (Techne) andsubjectedtothefollowing amplification
conditions: 1 cycle of 95uC for 2 min, 35 cycles of 95uC for 30s,
55uCfor40s,and65uCfor5 min,anda singleextensionof65uCfor
5 min. The resultant 4.9kb nanJ PCR product, 2.8 kb nanI PCR
product, or 2.3 kb nanH PCR product were each separately cloned
into the Invitrogen pCR2.1 TOPO vector according to the
manufacturer’s instruction and inserts were then sequenced at the
University of Pittsburgh Core Sequencing Facility. Using BamHI
and SalI, the nanJ insert was removed from the TOPO vector and
ligated into the pJIR751 C. perfringens/E. coli shuttle plasmid,
forming a plasmid named pJIR751nanJcomp (Table 1). Using the
same method, nanI and nanH inserts were separately cloned into
pJIR750 and pJIR751 C. perfringens/E. coli shuttle plasmids, forming
plasmids named pJIR750nanIcomp and pJIR751nanHcomp,
respectively (Table 1). These plasmids were individually introduced,
by standard electroporation techniques, into the BMC207 null
mutantstraintocreate nanJ, nanIand nanHcomplementationstrains
named, respectively, BMC2071, BMC2072 and BMC2073
(Table 1).
Western blot analyses
A 0.2 ml aliquot of an overnight FTG culture of the wild-type,
null mutants or complementing strains was inoculated into 10 ml
of TH medium. To perform ETX and sialidase Western blots,
supernatants of 8 h or overnight TH cultures were used. Samples
were collected and each supernatant (or the sonicated whole
culture) was mixed with SDS loading buffer and boiled for 5 min.
Those mixtures were electrophoresed on a 12% polyacrylamide
gel containing SDS for analyzing ETX or an 8% polyacrylamide
gel containing SDS for analyzing sialidase proteins. The gels were
then subjected to Western blotting using appropriate antibodies, as
previously described [31].
Sialidase enzyme activity assay
To assay sialidase enzyme activity, a previously described
protocol was used [20] Briefly, 20 ml of TH culture supernatant
was added to 60 ml of 100 mM sodium acetate buffer (pH 7.2) in
a microtiter tray. A 20 ml of aliquot 4 mM 5-bromo-4-chloro-3-
indolyl-a-D-N-acetylneuraminic acid (Sigma) was then added,
and the tray was incubated at 37uC for 30 min. The absorbance
at 595 nm was then determined using a microplate reader (Bio-
Rad).
Growth rate measurement for wild type, mutant and
complementing strains
A 0.1 ml aliquot of an FTG overnight culture of the wild-type
strain, null mutants or complementing strains was transferred to
TH medium, which was grown at 37uC overnight. A 0.2 ml
aliquot of each TH overnight culture was then inoculated into
10 ml of pre-warmed TH medium and the OD600 of those
cultures was measured at 37uC over time to determine vegetative
growth, as described previously [32].
Cell culture
Madin-Darby Canine Kidney (MDCK) epithelial cells were
cultured in a 1:1 (v/v) mix of Dulbecco’s Modified Eagle’s
Medium (DMEM, Sigma) and Nutrient Mixture F12 HAM
(Sigma), supplemented with 3% fetal bovine serum (Media-
tech), 100 mg/ml penicillin/streptomycin (Sigma) and 1%
glutamine (Sigma). Caco-2 cells were maintained in Eagle
minimal essential medium (Sigma) supplemented with 10%
fetal bovine serum (Mediatech), 1% nonessential amino acids
(Sigma), and 100 mg/ml of penicillin/streptomycin. Vero cells
were cultured in M199 medium (Sigma) supplemented with 5%
fetal bovine serum and 100 mg/ml of penicillin/streptomycin.
HT-29 cells were cultured in RPM1-164 medium (Sigma)
supplemented with 10% fetal bovine serum and 100 mg/ml of
penicillin/streptomycin. NT6 fibroblast cells were culture in
Alpha-MEM (Modified Eagle Medium) supplemented with
7.5% fetal bovine serum, 2 mM L-glutamine, 16Non Essential
Amino Acids, 1 mM sodium pyruvate, and 100 mg/ml of
penicillin/streptomycin. All cells were grown at 37uCw i t h5 %
atmospheric CO2.
Cytotoxicity assays
Prior to use in ETX cytotoxicity assays, purified ETX
prototoxin was activated by trypsin. For this purpose, 50 ml
aliquots of labeled or unlabeled prototoxin (2 mg/ml) were
incubated with 12.5 mg of trypsin (Sigma)/mg prototoxin for 1 h
at 37uC. After that incubation, trypsin inhibitor (Sigma) (1:1 v/v)
was added to remove trypsin activity. The same trypsin/trypsin
inhibitor mix (no ETX) was used as a negative control for
cytotoxicity assays. Confluent monolayer MDCK cells were
incubated in the presence or absence of 5 mg/ml of activated
ETX; in some experiments, that same amount of activated ETX
was added to a 10 6 concentrated TH supernatant culture for
1h ra t3 7 uC. After this incubation, cytotoxicity was measured
using the LDH Cytotoxicity Detection Kit (Roche).
Trypsin or chymotrypsin treatment of NanI and culture
supernatants
An aliquot of 0.005 U/ml NanI (Roche) or 8 h TH culture
supernatants of BMC206, BMC207, BMC2071, BMC2072 or
BMC2073 were incubated with 12.5 mg of trypsin (Sigma) or
chymotrypsin (Sigma) for 1 h at 37uC. After that incubation with
trypsin, trypsin inhibitor (Sigma) (1:1 v/v) was added to remove
trypsin activity from those samples. Sialidase activities were
detected by the method described before [20].
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Confluent monolayers of MDCK cells grown in 6 well cluster
plates (Corning) were or were not pretreated with 0.005 U/ml or
0.001 U/ml of C. perfringens sialidase (Roche) for 30, 60, or 90 min.
After this treatment, 5 mg/ml of AF488-ETX was added and the
cells were then further incubated for 60 min at 37uC. Following
this toxin challenge, the cells were harvested and washed twice
with PBS buffer and the pellets were then resuspended in 50 mlo f
PBS. After treatment of those asample with 1 ml of Benzonase
nuclease (Novagen) for 5 min at room temperature, 12 mlo f
56SDS loading buffer was added. These samples were then
electrophoresed on a SDS-containing 8% polyacrylamide gel, in
the dark. The resultant gel was imaged using a Typhoon 9400
variable mode imager (Amersham Biosciences), with fluorescence
emission set to detect the Alexa Fluor 488 label using the green
laser with wavelength 532 nm. For detection of the molecular
weight markers, the red laser was used with a wavelength of
633 nm. Complex formation was then quantified using Image-
quant version 5.2 (Molecular Dynamics).
To evaluate ETX binding, confluent monolayers of MDCK
cells grown in 24 well cluster plates (Corning) were pretreated with
a 0.005 U/ml or 0.001 U/ml of NanI sialidase at 37uC, and then
challenged with 5 mg/ml of AF488-pETX suspended in 250 mlo f
buffer or culture supernatants (from BMC206, BMC207,
BMC2071, BMC2072, BMC2073) that had been concentrated
106 using an Ultrafiltration centrifuge tube (Millipore). After
60 min at 37uC, the cells were harvested and washed twice in PBS.
The washed pellets were then resuspended in 50 ml of RIPA buffer
(Invitrogen) and added to 96-well plates, where fluorescence was
quantified using a Multi-mode Microplate Reader (Synergy
TM4,
BioTek).
Analysis of sialidase production after C. perfringens strains
contact Caco-2 cells, HT29 cells, NT6, Vero cells and
MDCK cells
A 0.1 ml aliquot of an FTG overnight culture of BMC206,
BMC207, BMC2071 or BMC2072 was transferred to TH
medium, which was grown at 37uC overnight. A 0.1 ml aliquot
of each TH overnight culture was then inoculated into fresh 10 ml
TH medium. These overnight cultures were centrifuged and the
pelleted cells were washed three times with HBSS buffer and then
resuspended in HBSS buffer at 10
7/ml. Confluent monolayers of
Caco-2 cells, MDCK cells, Vero cells, HT-29 cells, and NT-6 cells
grown in 6 well cluster plates were washed three times with HBSS
and then challenged with a 1 ml aliquot of the washed bacterial
cell suspension. Following anaerobic incubation at 37uC, for 2, 4,
or 6 h, the supernatants were removed, centrifuged and 60 ml
supernatant aliquot were used to measure sialidase activity by the
method described above, except the sample was incubated at room
temperature overnight instead of 37uC for 30 min before the
absorbance was read in order to increase assay sensitive. Control
washed bacterial cell suspensions were treated similarly except for
the absence of cells.
RNA isolation and qRT-PCR
As described previously [25], total RNA was extracted from
1 ml of a 2, 4, or 6 h culture of BMC206 that had or had not been
in contact with Caco2 cells. All RNA samples were treated with
DNAaseI (Promega). The purified RNA was quantified by
absorbance at 260 nm and stored in a -80uC freezer.
qRT-PCR reactions were performed on the purified RNA
samples using the iScript
TM one-step RT-PCR kit with SYBR
green (Bio-Rad). Briefly, 100 ng of each RNA sample was reverse-
transcribed to cDNA at 50uC for 10 min. That cDNA was then
used as template for PCR reactions with primers 16sF and 16sR
(Table 2) targeting the 16sRNA as a housekeeping gene; primers
nanIKOF and nanIKOR targeting the nanI gene, primers
nanJKOF and nanJKOR targeting the nanJ gene, or primers
nanHKOF and nanHKOR targeting the nanH gene (Table 2). All
reactions were performed at AB Appled Biosystems Step One plus
Real-Time PCR system.
Attachment assays
A 1.5 ml aliquot of a TH overnight culture of BMC206,
BMC207, BMC2071, BMC2072 or BMC2073 was centrifuged
and the bacterial pellet was then washed three times with HBSS
buffer. After resuspension of the washed pellet in 1.5 ml of HBSS
buffer, these suspensions were serially diluted from 10
-2 to 10
-7
with sterile water and aliquots were spread onto BHI agar plates.
Following an overnight anaerobic incubation at 37uC, the colonies
arising on these plates were counted to determine the number of
CFU added to the mammalian cell cultures. Monolayers of Caco-
2, HT-29, Vero, MDCK or NT6 fibroblasts were then incubated
under anaerobic conditions with a 100 ml aliquot of these washed
bacteria for 2 h at 37uC. After this incubation, the monolayers
were washed with HBSS three times and host cell-associated
bacteria were retrieved by lysing the monolayers in distilled water.
Aliquots of these suspensions were plated onto BHI agar plates.
After overnight anaerobic incubation at 37uC, the colonies arising
on the plates were used to calculate the number of adherent CFU.
Immunofluorescence microscopy
Caco-2 cells were grown to confluency in an 8-well chamber
slide (Fisher). A 1 ml aliquot of a BMC206, BMC207 and
BMC2072 overnight TH culture was added to each chamber of
the slide, and the slide was then incubated at 37uC for 2 h. Cells
were washed three times with HBSS buffer. The slides were fixed
in 4% formaldehyde in HBSS for 30 min at room temperature.
The fixed cells were incubated with a 1:500 dilution of anti-C.
perfringens rabbit polyclonal antibody (Genway) in HBSS with 10%
BSA for 2 h at room temperature. Those cells were then washed
three times with HBSS buffer and incubated with 1:500 Alexa
Fluor-488 goat anti-rabbit IgG (Invitrogen) in HBSS with 10%
BSA for 1 h at room temperature. After 3 more washes with
HBSS buffer, the cells were incubated with 1:200 Vybrant
TM Cell-
labeling solutions (Molecular Probes) for 30 min at room
temperature. Following a final three washes with HBSS buffer,
the chambers were removed, and a coverslip was mounted with
Fluoro-Gel (Electron Microscopy Sciences). Imaging was per-
formed on a Zeiss Axioskop 40 immunofluorescence microscope.
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